Lithium does not directly alter agonist-stimulated phosphoinositide-specific phospholipase C activation in rat brain
1Department of Biochemistry, University of Tennessee, Memphis, 800 Madison Avenue, Memphis, Tennessee 38163, USA.
Abstract:
The effects of Li(+) on phosphoinositide-specific phospholipase C activation in rat cerebral cortical slices and membranes were examined. In rat brain cortical slices labeled with [(3)H]inositol, the accumulation of labeled inositol phosphates due to carbachol was enhanced in the presence of Li(+). There was no greater effect of Li(+) in the presence of agonists if slices were exposed to 20 mM Li(+) for 6 h and then tested in the presence of Li(+) or if slices were prepared from rats injected twice daily with 10 meq/kg of LiCl or NaCl for 3 days. In membranes prepared from cortical slices, Li(+) had no effect on basal or on guanosine 5-O-(3-thio)triphosphate (GTPgammaS) or GTPgammaS plus carbachol stimulation of phospholipase C activity. The activation of phospholipase C in brain membranes by 1 mM carbachol or 100 muM norepinephrine in the presence of GTPgammaS was not affected if membranes were prepared from rats injected for 3 days with LiCl. In conclusion, Li(+)in vitro does not alter phospholipase C activation by carbachol or norepinephrine in brain cortical membranes.
Related Concept Videos
IP3/DAG Signaling Pathway
Ligand-Gated Ion Channel Receptor: Gating Mechanism
GPCRs Regulate Adenylyl Cylase Activity
Two...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Direct-Acting Cholinergic Agonists: Pharmacokinetics


